Guang Fang Ji, the root of Aristolochia fangchi Y. C. WU ex L. D. CHOU et S. M. HWANG (Aristolochiaceae), is distributed in many places of southeastern of China. For thousands of years it has been used in traditional Chinese medicine to treat arthritis, rheumatism, and edema of the lower extremities.
Guang Fang Ji, the root of Aristolochia fangchi Y. C. WU ex L. D. CHOU et S. M. HWANG (Aristolochiaceae), is distributed in many places of southeastern of China. For thousands of years it has been used in traditional Chinese medicine to treat arthritis, rheumatism, and edema of the lower extremities. 1) However, in the last 20 years it has been found that Aristolochia plants (which contain aristolochic acids compounds) can cause serious kidney damage, and the products of aristolochia species have also been linked to certain types of cancer, most often occurring in the urinary tract. [2] [3] [4] [5] [6] Therefore many countries including China have banned the use of plants that contain aristolochic acid. 7) Much attention has been paid to the chemical constituents, the nephrotoxic and carcinogenic effects of aristolochic acid derivatives, and the corresponding plants for years. Several aristolochic acids and aristolactams have been isolated from this plant. [8] [9] [10] In the course of our systemic investigation of the chemical constitutes and their toxicities, two new and three known compounds from the roots of Aristolochia fangchi were isolated. This paper deals with the structure determination of the new compounds and cytotoxicities of the compounds obtained.
Results and Discussion
The air-dried and powdered roots of Guang Fang Ji were extracted with 90% ethanol, and the extracts were separated as described in the experimental section to yield compounds 1-5. The three known compounds were identified as aristolochic acid A (1), aristolochic acid B (2), and aristolochic acid C (3) by comparison of their spectral data with data reported in the literature [11] [12] [13] [14] [15] (Fig. 1 ). Compound 4 was obtained as a yellow amorphous powder. The high resolution MS analysis of quasimolecular ion peaks in the positive-ion FAB-MS of 4 showed a molecular ion peak at m/z 328.2459, indicating a molecular formula of C 16 H 9 NO 7 . The UV absorption of 4 at 218, 256, 295, 351, and 371 nm showed it was a phenanthro type derivative. 11, 15) Its IR spectrum showed absorption bands due to hydroxyl, nitro, and carboxyl functions at 3438, 1337, 1520, and 1715 cm 14) and a hydroxyl group was believed to be connected at C-7. The remaining 2 one-proton signals at d 7.72 (1H, s) and 8.21 (1H, s) could be ascribed to H-2 and H-9, respectively, due to the anisotropic effect of the carbonyl group at C-1. 14, 15) One singlet signal at d 6.48 (2H, s) was attributed to methylenedioxyl protons. 11, 13) All substituted groups and positions were confirmed by heteronuclear multiple bond connectivity (HMBC) and nuclear Overhauser effect spectroscopy (NOESY) experiments ( These spectral findings confirmed that the hydroxyl group was substituted at C-7. Based on the above evidence, compound 4 was determined as a new constituent, and named Aristolochic Acid F.
Compound 5 was obtained as a yellowish-brown amorphous powder. The high resolution MS analysis of quasimolecular ion peaks in the positive-ion FAB-MS of 5 showed a molecular ion peak at m/z 344.2462, indicating a molecular formula of C 16 13 C-NMR spectral data (Table 2) 15) and two hydroxyl groups were believed to be connected at C-6 and C-8. The remaining 2 one-proton signals at d 7.76 (1H, s) and 8.70 (1H, s) could be ascribed to H-2 and H-9, respectively, due to the anisotropic effect of the carbonyl group at C-1. One singlet signal at d 6.50 (2H, s) was attributed to methylenedioxyl protons. In the HMBC spectrum (Fig. 3) 6 ). These spectral findings confirmed that two hydroxyl groups were substituted at C-6 and C-8. Based on the above evidence, compound 5 was determined as a new constituent, and named Aristolochic Acid G.
From the results of cytotoxic activity testing (Table 3) , compound 1, as predicted from previous data, 16) showed intensive cytotoxic activity against LLC-PK 1 cells with an 1094 Vol. 58, No. 8 Assay of Cytotoxic Activities against LLC-PK 1 Cells The isolated compounds 1-5 were evaluated for their cytotoxic activity against LLC-PK 1 cells using a method described in the literature. 16 ) Doxorubicin was used as the positive control and hederasaponin C was used as the negative control (Table 3 ). An IC 50 value over 300 mmol/l was considered to indicate no cytotoxic activity against LLC-PK 1 cells.
Aristolochic Acid A ( Tables 1  and 2 .
